Pioneering a Synapse Protecting Oral Therapy

Our Mission

Protecting every connection to preserve the essence of who we are.

Allyx Therapeutics is dedicated to transforming the treatment landscape for Alzheimer’s disease and neurodegeneration. By pioneering oral small molecule therapies that protect synapses from toxic misfolded proteins, we aim to deliver meaningful clinical impact for patients, caregivers, and families worldwide.

Committed to Making an impact

A Better Treatment for Alzheimer's

We understand firsthand the immense need for better treatments. Instead of standing by awaiting iterative change, we decided to make an impact and lead the radical advance in therapies we want available for our families, now and in the future.